<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01256983</url>
  </required_header>
  <id_info>
    <org_study_id>SleepTx-1</org_study_id>
    <nct_id>NCT01256983</nct_id>
  </id_info>
  <brief_title>Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation</brief_title>
  <acronym>SleepTx-1</acronym>
  <official_title>Daily Light Intervention in Renal Transplant Recipients Having a Sleep-Wake Dysregulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, ZÃ¼rich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Basel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep-wake dysregulation is a disturbance in the roughly 24-hour cycle of the circadian
      rhythm. Well known disorders presenting a sleep-wake dysregulation are seasonal affective
      disorder, jet lag and shift work. These people experience a serious mood change when the
      seasons change. When the day-night rhythm is desynchronized, they have sleep disturbances,
      little energy, and often feel depressed. An established intervention to treat this disorder
      is bright light therapy. Light therapy is used for affective disorders for shift workers, jet
      lag symptomatology and for advancing or delaying desynchronized rhythms.Two proxy measures
      for sleep-wake dysregulation are sleep quality and daytime sleepiness. It is known from cross
      sectional studies that renal transplant (RTx) recipients have a prevalence between 30% to 62%
      of poor sleep quality measured by self report; a prevalence of impaired daytime functioning
      of 34% 12 and a prevalence of depressive symptomatology of 20% to 22%. Sleep-wake
      dysregulation in other chronically ill population are a risk factor for morbidity and
      mortality.

      RTx nurses in the follow-up care are in the frontline for recipient's symptoms respectively
      problems. The psychosocial variables that should be addressed, having an association with
      morbidity and mortality are sleep, daytime functioning, adherence to immunosuppressive
      medication, exercise, smoking and depressive symptomatology.

      In the following research project we will address the following gaps: the fact that nature of
      sleep disturbances in RTx recipients has never been assessed, that there is no prevalence
      available on sleep-wake dysregulation and that there is no data on bright light therapy
      intervention in RTx recipients.

      Hypothesis: Renal transplant recipients having a sleep wake disregulation will have an
      improved sleep quality and less daytime sleepiness after 21 days of light therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research project has three phases:

      The first phase is a cross sectional survey including all patients transplanted in Basel,
      Bern and in Zurich speaking German and transplanted at least 6 months ago. Renal transplant
      recipients having poor sleep quality and / or daytime sleepiness as result of this first
      phase will be asked to participate in phase two. Phase two is an sleep assessment, resulting
      in a presumed sleep diagnosis.

      Renal transplant recipients having a sleep wake dysregulation, assessed in phase two, will be
      asked to participate in phase three. Phase three is a pilot randomized controlled trial to
      compare the sustained impact of bright light therapy on sleep-wake regulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bedtime</measure>
    <time_frame>Mean Bedtimes over 21 days for each period</time_frame>
    <description>The mean &quot;bedtime&quot; assessed by actimetry of each 3 week period (day 21, 42, 63 ) was used as outcome to be compared with the control group.
Bedtime is expressed in time (hours and minutes)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Renal Disease</condition>
  <condition>Sleep Disorders</condition>
  <arm_group>
    <arm_group_label>Bright Light Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bright Light Therapy with 10000 lux beginning at day 21 until day 42</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait-list intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Wait-list design Intervention. Bright Light Therapy with 10000 lux beginning at day 63 until day 84, when the 9 study weeks were over.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Bright Light Therapy</intervention_name>
    <description>10000 Lux for 30 Minutes according to sleep wake rhythm</description>
    <arm_group_label>Bright Light Therapy</arm_group_label>
    <other_name>Philips Energy Light</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Wait-list intervention</intervention_name>
    <description>10000 Lux for 30 Minutes according to sleep wake rhythm</description>
    <arm_group_label>Wait-list intervention</arm_group_label>
    <other_name>Philips Energy Light</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For phase 1: all renal transplant recipients transplanted at the University Hospital
             Basel, Bern and Zurich, speaking German and having an actual address on the follow-up
             list of the ambulatory center list.

          -  Renal transplant recipients who have poor Sleep quality and /or daytime sleepiness
             (phase 1: Cross sectional survey study) and had a Sleep assessment (phase 2: Cross
             sectional diagnostic interview study)

          -  Renal transplant recipients who participated in Phase 1 and 2 that were diagnosed with
             sleep wake dysregulation

          -  Renal transplant recipients with signed written informed consent.

        Exclusion Criteria:

          -  RTx recipients, who participated in phase 2, will be excluded in the study if

               -  they were diagnosed with sleep disorders as parasomnia, breathing disorders or
                  movement disorders.

               -  they were diagnosed with alcohol or substance abuse

               -  they are blind or suffer from a severe vision impairment (cataract), which
                  possibly limits the effect of the light intervention and patients taking
                  photosensitive medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabina De De Geest, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Nursing Science</affiliation>
  </overall_official>
  <removed_countries>
    <country>Switzerland</country>
  </removed_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2010</study_first_submitted>
  <study_first_submitted_qc>December 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2010</study_first_posted>
  <results_first_submitted>September 26, 2013</results_first_submitted>
  <results_first_submitted_qc>December 10, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 28, 2014</results_first_posted>
  <last_update_submitted>January 29, 2014</last_update_submitted>
  <last_update_submitted_qc>January 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Basel</investigator_affiliation>
    <investigator_full_name>Hanna Burkhalter</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Sleep quality</keyword>
  <keyword>Daytime Sleepiness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>49 patients were recruited</recruitment_details>
      <pre_assignment_details>19 declined to participate after initial interest</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Light Box</title>
          <description>10000 lux after day 21
Light Box : 10000 Lux for 30 Minutes according to sleep wake rhythm</description>
        </group>
        <group group_id="P2">
          <title>No Intervention</title>
          <description>10000 Lux after day 63</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Light Box</title>
          <description>10000 lux after day 21
Light Box : 10000 Lux for 30 Minutes according to sleep wake rhythm</description>
        </group>
        <group group_id="B2">
          <title>No Intervention</title>
          <description>10000 Lux after day 63</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.72" spread="10.33"/>
                    <measurement group_id="B2" value="58.54" spread="14.91"/>
                    <measurement group_id="B3" value="59.63" spread="12.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Bedtime</title>
        <description>The mean &quot;bedtime&quot; assessed by actimetry of each 3 week period (day 21, 42, 63 ) was used as outcome to be compared with the control group.
Bedtime is expressed in time (hours and minutes)</description>
        <time_frame>Mean Bedtimes over 21 days for each period</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Light Box</title>
            <description>10000 lux after day 21
Light Box : 10000 Lux for 30 Minutes according to sleep wake rhythm</description>
          </group>
          <group group_id="O2">
            <title>No Intervention</title>
            <description>10000 Lux after day 63</description>
          </group>
        </group_list>
        <measure>
          <title>Bedtime</title>
          <description>The mean &quot;bedtime&quot; assessed by actimetry of each 3 week period (day 21, 42, 63 ) was used as outcome to be compared with the control group.
Bedtime is expressed in time (hours and minutes)</description>
          <units>Hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Getup time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.44" spread="1.69"/>
                    <measurement group_id="O2" value="7.24" spread="1.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bedtime</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.98" spread="1.78"/>
                    <measurement group_id="O2" value="22.48" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 months</time_frame>
      <desc>2 months beginning with the start of the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Bright Light Therapy</title>
          <description>Bright Light Therapy with 10000 lux beginning at day 21 until day 42</description>
        </group>
        <group group_id="E2">
          <title>Wait-list Intervention</title>
          <description>Wait-list design Intervention. Bright Light Therapy with 10000 lux beginning at day 63 until day 84, when the 9 study weeks were over.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was very long and burdensome for the participants, a full powered study should be shorter.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Mrs. Hanna Burkahlter</name_or_title>
      <organization>University Hospital ZÃ¼rich</organization>
      <phone>0041 76 371 12 35</phone>
      <email>hanna.burkhalter@usz.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

